HUP0100130A2 - Rekombináns Mycoplasma hyopneumoniae vakcina - Google Patents
Rekombináns Mycoplasma hyopneumoniae vakcinaInfo
- Publication number
- HUP0100130A2 HUP0100130A2 HU0100130A HUP0100130A HUP0100130A2 HU P0100130 A2 HUP0100130 A2 HU P0100130A2 HU 0100130 A HU0100130 A HU 0100130A HU P0100130 A HUP0100130 A HU P0100130A HU P0100130 A2 HUP0100130 A2 HU P0100130A2
- Authority
- HU
- Hungary
- Prior art keywords
- mycoplasma
- hyopneumoniae
- pneumonia
- antigenicity
- subject
- Prior art date
Links
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 abstract 3
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 102100022589 Coatomer subunit beta' Human genes 0.000 abstract 1
- 101710181675 Coatomer subunit beta' Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgyát a Mycoplasma hyopneumoniae (M.hyopneumoniae vagy M. hyo) p102 proteinjének antigenitását hordozóprotein képezi. A találmány tárgya továbbá a Mycoplasma-pneumonia,közelebbről a sertések Mycoplasma-pneumoniája ellen védettséget nyújtóvakcina, prokaryota vagy eukaryota gazdasejtben a természetes P102antigenitásával rendelkező polipeptidtermék expresszióját eredményezőDNS, valamint diagnosztikai reagenskészletek. A találmány tárgyátképezik továbbá eljárások egy állat Mycoplasma hyopneumoniae okoztaMycoplasma-pneumonia ellen védetté tételére, valamint vizsgálatimintából P102-ellenanyagok jelenlétének kimutatására. A találmányszerinti megoldás alkalmas Mycoplasma-hyopneumoniae fertőzések, ésennek szövődményeként fellépő fertőzések kezelése és megelőzéseterületén. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6656597P | 1997-11-26 | 1997-11-26 | |
| PCT/US1998/025044 WO1999026664A1 (en) | 1997-11-26 | 1998-11-24 | Recombinant mycoplasma hyopneumoniae vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0100130A2 true HUP0100130A2 (hu) | 2001-05-28 |
Family
ID=22070298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100130A HUP0100130A2 (hu) | 1997-11-26 | 1998-11-24 | Rekombináns Mycoplasma hyopneumoniae vakcina |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6162435A (hu) |
| EP (1) | EP1034004A1 (hu) |
| JP (1) | JP2001523481A (hu) |
| KR (1) | KR20010032493A (hu) |
| CN (1) | CN1301180A (hu) |
| AU (1) | AU1535299A (hu) |
| BR (1) | BR9815321A (hu) |
| CA (1) | CA2311759A1 (hu) |
| HU (1) | HUP0100130A2 (hu) |
| ID (1) | ID26951A (hu) |
| PL (1) | PL341797A1 (hu) |
| WO (1) | WO1999026664A1 (hu) |
| ZA (1) | ZA9810774B (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002309109B2 (en) | 2001-07-02 | 2007-12-13 | Zoetis Services Llc | One dose vaccination with mycoplasma hyopneumoniae |
| DK1546357T3 (da) * | 2002-06-28 | 2013-09-02 | Univ Iowa State Res Found Inc | Immunogene polypeptider af mycoplasma pneumoniae |
| US8546149B2 (en) | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
| WO2012025612A1 (en) * | 2010-08-27 | 2012-03-01 | Intervet International B.V. | Potency test for vaccine formulations |
| UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| KR101503907B1 (ko) * | 2013-01-17 | 2015-03-20 | 서울대학교산학협력단 | 흉막폐렴균과 마이코플라즈마 하이오뉴모니아 감염 질환 예방을 위한 재조합 단백질 백신 |
| WO2015048115A1 (en) | 2013-09-25 | 2015-04-02 | Zoetis Llc | Pcv2b divergent vaccine composition and methods of use |
| CN108623663B (zh) * | 2018-05-14 | 2021-09-21 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 猪肺炎支原体p97蛋白的免疫原性功能多肽及其编码基因和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4170646A (en) * | 1978-07-17 | 1979-10-09 | American Cyanamid Company | Method for the control of Mycoplasma hyopneumoniae in swine with alkylated BM123γ type antibiotics |
| FR2578859B1 (fr) * | 1985-03-12 | 1989-09-08 | Commissariat Energie Atomique | Appareillage et installation de realisation d'un depot metallique electrolytique d'epaisseur constante. |
| US4894332A (en) * | 1985-03-27 | 1990-01-16 | Biogen, Inc. | DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins |
| US5252328A (en) * | 1987-03-26 | 1993-10-12 | Martin Marietta Energy Systems, Inc. | Mycoplasma hyopneumoniae antigen and uses therefor |
| US5240706A (en) * | 1989-04-07 | 1993-08-31 | Ml Technology Ventures, L.P. | Intranasal administration of Mycoplasma hyopneumoniae antigen |
| WO1991015593A1 (en) * | 1990-04-02 | 1991-10-17 | Synergen, Inc. | Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| US5338543A (en) * | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| US5712090A (en) * | 1993-05-18 | 1998-01-27 | Iowa State University Research Foundation, Inc. | PCR-based assay for Mycoplasma hyopneumoniae |
| US5788962A (en) * | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
-
1998
- 1998-11-24 HU HU0100130A patent/HUP0100130A2/hu unknown
- 1998-11-24 PL PL98341797A patent/PL341797A1/xx unknown
- 1998-11-24 CN CN98812847A patent/CN1301180A/zh active Pending
- 1998-11-24 US US09/198,484 patent/US6162435A/en not_active Expired - Lifetime
- 1998-11-24 KR KR1020007005735A patent/KR20010032493A/ko not_active Application Discontinuation
- 1998-11-24 JP JP2000521865A patent/JP2001523481A/ja active Pending
- 1998-11-24 EP EP98959583A patent/EP1034004A1/en not_active Withdrawn
- 1998-11-24 CA CA002311759A patent/CA2311759A1/en not_active Withdrawn
- 1998-11-24 WO PCT/US1998/025044 patent/WO1999026664A1/en not_active Application Discontinuation
- 1998-11-24 BR BR9815321-8A patent/BR9815321A/pt not_active Application Discontinuation
- 1998-11-24 AU AU15352/99A patent/AU1535299A/en not_active Abandoned
- 1998-11-24 ID IDW20001242A patent/ID26951A/id unknown
- 1998-11-25 ZA ZA9810774A patent/ZA9810774B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1034004A1 (en) | 2000-09-13 |
| JP2001523481A (ja) | 2001-11-27 |
| CN1301180A (zh) | 2001-06-27 |
| BR9815321A (pt) | 2002-01-02 |
| WO1999026664A1 (en) | 1999-06-03 |
| US6162435A (en) | 2000-12-19 |
| CA2311759A1 (en) | 1999-06-03 |
| ID26951A (id) | 2001-02-22 |
| KR20010032493A (ko) | 2001-04-25 |
| PL341797A1 (en) | 2001-05-07 |
| AU1535299A (en) | 1999-06-15 |
| ZA9810774B (en) | 1999-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Taverna et al. | Characterization of cell wall associated proteins of a Staphylococcus aureus isolated from bovine mastitis case by a proteomic approach | |
| BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
| EA200000860A1 (ru) | Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) | |
| Seco-Mediavilla et al. | Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis | |
| BR0015137A (pt) | Peptìdeos antigênicos de neisseria | |
| BR9712518A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico | |
| BR0208874A (pt) | Proteìnas superficiais de streptococcus pyogenes | |
| ATE519844T1 (de) | Zusammensetzungen und verfahren zur erkennung, diagnose und therapie von hämatologischen malignomen | |
| HUP0500459A2 (hu) | Streptococcus suis vakcinák és diagnosztikai tesztek | |
| Reglinski et al. | Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG | |
| TR200102497T2 (tr) | Yeni streptococcus antijenleri | |
| BR0016066A (pt) | Compostos e métodos para tratamento e diagnóstico de infecção clamidial | |
| DK53595A (da) | Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner | |
| NO329875B1 (no) | Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer. | |
| HUP0100130A2 (hu) | Rekombináns Mycoplasma hyopneumoniae vakcina | |
| ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
| Denoel et al. | Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB | |
| NZ331989A (en) | Arthritogenic peptide, DNAJ, isolated from bacterial peptides and used in vaccine compositions for treating rheumatoid arthritis | |
| Langedijk et al. | A structural model of pestivirus Erns based on disulfide bond connectivity and homology modeling reveals an extremely rare vicinal disulfide | |
| DE69638024D1 (de) | Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren | |
| DE3650011D1 (de) | EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND. | |
| Kokai-Kun et al. | Determination of functional regions of Clostridium perfringens enterotoxin through deletion analysis | |
| Chen et al. | Evaluation of the protective efficacy of a newly identified immunogenic protein, HP0272, of Streptococcus suis | |
| DE69534186D1 (de) | Impfstoff gegen Streptokokkeninfektionen der Gruppe A | |
| Mandanici et al. | A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection |